Get the Stockscreener App
5.60
1.06%
-0.06
After Hours:
5.60
Voyager Therapeutics Inc Stock (VYGR) Latest News
Voyager to Present at Oppenheimer 25th Annual Healthcare Life Sciences Conference - GlobeNewswire
Neurogenetic Medicine Pioneer Voyager Sets Stage for Major Healthcare Conference Appearance - StockTitan
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Rating of “Buy” from Analysts - Defense World
Voyager: Crossing The Blood-Brain Barrier, Competitors, And Investment Relevance (VYGR) - Seeking Alpha
What Makes Voyager Therapeutics (VYGR) a New Buy Stock - Yahoo Finance
(VYGR) On The My Stocks Page - Stock Traders Daily
Voyager Therapeutics (NASDAQ:VYGR) Given “Buy” Rating at HC Wainwright - Defense World
H.C. Wainwright maintains $30 target on Voyager Therapeutics stock - Investing.com India
HC Wainwright Reiterates "Buy" Rating for Voyager Therapeutics (NASDAQ:VYGR) - MarketBeat
Reviewing Voyager Therapeutics (NASDAQ:VYGR) and Kyverna Therapeutics (NASDAQ:KYTX) - Defense World
Q1 Earnings Estimate for VYGR Issued By Leerink Partnrs - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock Position Lowered by JPMorgan Chase & Co. - Defense World
Analysts Issue Forecasts for VYGR FY2025 Earnings - Defense World
Wedbush assumes coverage of Voyager with outperform rating - MSN
Cantor Fitzgerald Comments on VYGR FY2025 Earnings - MarketBeat
Voyager Therapeutics up 8% following quarterly beats - MSN
Is it a Good Idea to Invest in Stoke Therapeutics Stock Now? - Yahoo Finance
Barclays PLC Grows Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Insider Sell: Robin Swartz Sells Shares of Voyager Therapeutics Inc - GuruFocus.com
Voyager Therapeutics chief scientific officer sells shares worth $6,109 By Investing.com - Investing.com Canada
Voyager Therapeutics COO Robin Swartz sells $15,712 in stock By Investing.com - Investing.com South Africa
Voyager Therapeutics, Inc. (NASDAQ:VYGR) COO Sells $15,712.83 in Stock - MarketBeat
Voyager Therapeutics chief scientific officer sells shares worth $6,109 - Investing.com
Cantor Fitzgerald Predicts VYGR FY2024 Earnings - Defense World
Analysts Issue Forecasts for VYGR FY2024 Earnings - MarketBeat
Even though Voyager Therapeutics (NASDAQ:VYGR) has lost US$40m market cap in last 7 days, shareholders are still up 80% over 3 years - Simply Wall St
Voyager Therapeutics stock hits 52-week low at $5.18 By Investing.com - Investing.com Canada
Voyager Therapeutics stock hits 52-week low at $5.18 - Investing.com India
Cantor Fitzgerald Begins Coverage on Voyager Therapeutics (NASDAQ:VYGR) - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Given Consensus Rating of “Buy” by Brokerages - Defense World
Cantor Fitzgerald Initiates Coverage of Voyager Therapeutics (VYGR) with Overweight Recommendation - MSN
Voyager Therapeutics (NASDAQ:VYGR) Coverage Initiated by Analysts at Cantor Fitzgerald - MarketBeat
Trend Tracker for (VYGR) - Stock Traders Daily
Jane Street Group LLC Lowers Stock Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Jane Street Group LLC Cuts Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - MarketBeat
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Shares Purchased by Geode Capital Management LLC - Defense World
Barclays PLC Boosts Stock Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Shares Sold by State Street Corp - Defense World
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Position Reduced by State Street Corp - MarketBeat
Voyager Therapeutics, Inc. (VYGR): Is This Gene Therapy Stock a Good Buy Right Now? - Yahoo Finance
How to Take Advantage of moves in (VYGR) - Stock Traders Daily
Voyager Therapeutics COO Robin Swartz sells shares worth $36,725 By Investing.com - Investing.com Australia
Voyager Therapeutics COO Robin Swartz sells shares worth $36,725 - Investing.com India
Robin Swartz Sells 6,500 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock - MarketBeat
Insider Sell: Robin Swartz Sells 6,500 Shares of Voyager Therape - GuruFocus.com
Should Weakness in Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - Simply Wall St
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):